Nonconvulsive status epilepticus: An under diagnosed and potentially treatable condition

Neurology India

Volumn 51, Issue 4, 2003, Pages 453-454

  Murthy, J M K ^a  

^a CARE HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CARBAMAZEPINE; MIDAZOLAM; PENTOBARBITAL; PROPOFOL; PSYCHOTROPIC AGENT; VALPROIC ACID; VIGABATRIN;

ABSENCE; BRAIN DISEASE; CLINICAL FEATURE; CONVULSION; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DRUG EFFICACY; EDITORIAL; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; GENERALIZED EPILEPSY; HUMAN; INTENSIVE CARE UNIT; MENTAL DEFICIENCY; MENTAL DISEASE; MENTAL HEALTH; MORBIDITY; MORTALITY; MYOCLONUS EPILEPSY; PATIENT MONITORING; TREATMENT PLANNING;

ANTICONVULSANTS; HUMANS; STATUS EPILEPTICUS;

EID: 1042303672     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (29)

1. Kaplah PW. Nonconvulsive status epilepticus. Seminars in Neurology 1996;16:33-40.
2. Towne AR, Waterhouse EJ, Morton LD, Kopee Garnett L, Brown AJ, DeLorenzo RJ. Unrecognized nonconvulsive status epilepticus in comatose patients. Epilepsia 1998;39:K07.
3. Celesia GG, Modern concepts of status epilepticus. JAMA 1976;235:1571-4.
4. Duane JW, Summers QA, Stewart-Wyne EG. Nonconvulsive status epilepticus: a prospective study in adult general hospital. Q J Med 1987;23:117-26.
5. Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of noncolivulsive status epilepticus in comatose patients. Neurology 2000;54:340-5.
6. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after control of convulsive status epilepticus. Epilepsia 1998;38:833-40.
7. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 1995;12:316-25.
8. Towne AR, Pellock JM, Ko D, et al. Determinants of mortality in status epilepticus: a retrospective study of 292 adult patients. Epilepsia 1994;35:27-34.
9. Guberman A, Cantu-Reyan G, Stuss D, Broughton R. Nonconvulsive generalized status epilepticus: clinical features, neuropsychological testing, and long-term follow-up. Neurology 1986;36:1284-91.
10. Lee SI. Nonconvulsive status epilepticus. Ictal confusion in later life. Arch Neurol 198.5;42:778-81.
11. Shneker BF, Fountain NB. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology 2003;61:1066-73.
12. Chemmanam T, Pandian JD, Singh YP, Pandhi M. Non convulsive status, epilepticus - A rare presentation of juvenile myoclonic epilepsy. Neurology India 2003;51:
13. Andermann F, Robb JP. Absence status: a reappraisal following review of thirty-eight patients. Epilepsia 1972;13:177-87.
14. Dziewas R, Kellinghaus C, Ludemann P Nonconvulsive status epilepticus in patients with juvenile myoclonic epilepsy: types still frequencies. Seizure 2002;11:335-9.
15. Tomson T, Lindbom U, Nilsson BY. Nonconvulsive status epilepticus in adults: thirty-two consecutive patients from a general hospital population. Epilepsia 1992;33:829-35.
16. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998;39:5-17.
17. Bauer J. Seizure-inducing effect of antiepileptic drugs: a review. Acts Neurol Scand 1996;94:367-77.
18. Berkovic SF. Aggravation of generalized epilepsies. Epilepsia 1998;39:S11-4.
19. Genton P, Gelisse P, Thomas P, Dravet C. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 2000;55:1106-9.
20. Panayitopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a prospective 5 year prospective study. Epilepsia 1994;35:285-96.
21. Murthy JMK, Mohan Rao Ch, Meena AK. Clinical observations of juvenile myoclonic epilepsy in 131 patients: a hospital-based study from south India. Seizure 1998;7:43-7.
22. Murthy JM. Factors involved in the diagnosis of juvenile myoclonic epilepsy: A study from South India. Neurol India 1999;47:210-3.
23. Young GB, Jordan KG, Doig GS. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring all investigation of variables associated with mortality. Neurology 1996;47:83-9.
24. Litt B, Wityk RJ, Herz SH, et al. Nonconvulsive status epilepticus in the critically ill elderly Epilepsia 1998;39:1194-202.
25. Mayer SA, Classen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory epilepticus: frequency, risk factors, and impact oil outcome. Arch Neurol 2002;59:205-10.
26. Kaplan PW. Intravenous valproate treatment of generalized nonconvulsive status epilepticus. Clin Electroencephalogr 1999;30:1-4.
27. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systemic review. Epilepsia 2002;43:146-53.
28. Thomas P, Beaumanoir A, Genton P, Dolisi C, Chatel M. "De nova" absence status of late onset: report of 11 cases. Neurology 1992;42:104-10.
29. Claassen J, Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA. Continuous EEG monitoring tind midazolam infusion for refractory nonconvulsive status epilepticus. Neurology 2001;57:1036-42.